Suri K, Pfeifer L, Cvet D, Li A, McCoy M, Singh A
Drug Deliv Transl Res. 2024; .
PMID: 39320435
DOI: 10.1007/s13346-024-01709-4.
Zheng Y, Luo S, Xu M, He Q, Xie J, Wu J
Acta Pharm Sin B. 2024; 14(9):3876-3900.
PMID: 39309496
PMC: 11413706.
DOI: 10.1016/j.apsb.2024.06.015.
Shahzad N, Alzahrani A, Ibrahim I, Shahid I, Alanazi I, Falemban A
Heliyon. 2024; 10(2):e24207.
PMID: 38298622
PMC: 10828662.
DOI: 10.1016/j.heliyon.2024.e24207.
Yosef A, Alqarni R, Sayd F, Alhawiti M, Almahlawi R, Prabahar K
Biomedicines. 2024; 12(1).
PMID: 38255231
PMC: 10813275.
DOI: 10.3390/biomedicines12010126.
Chen M, Lan H, Jin K, Chen Y
Drug Deliv. 2023; 30(1):2219427.
PMID: 37288799
PMC: 10405869.
DOI: 10.1080/10717544.2023.2219427.
Preparation and Characterization of a Novel Multiparticulate Dosage Form Carrying Budesonide-Loaded Chitosan Nanoparticles to Enhance the Efficiency of Pellets in the Colon.
Soltani F, Kamali H, Akhgari A, Rahbardar M, Afrasiabi Garekani H, Nokhodchi A
Pharmaceutics. 2023; 15(1).
PMID: 36678698
PMC: 9865799.
DOI: 10.3390/pharmaceutics15010069.
Formulation of pH-Responsive Methacrylate-Based Polyelectrolyte-Stabilized Nanoparticles for Applications in Drug Delivery.
Kim B, Zhang D, Armstrong M, Pelczer I, Prudhomme R
ACS Appl Nano Mater. 2022; 5(12):18770-18778.
PMID: 36583123
PMC: 9791616.
DOI: 10.1021/acsanm.2c04539.
Immunomodulation in age-related disorders and nanotechnology interventions.
Chintapula U, Chikate T, Sahoo D, Kieu A, Guerrero Rodriguez I, Nguyen K
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 15(1):e1840.
PMID: 35950266
PMC: 9840662.
DOI: 10.1002/wnan.1840.
A Review on the Delivery of Plant-Based Antidiabetic Agents Using Nanocarriers: Current Status and Their Role in Combatting Hyperglycaemia.
Zolkepli H, Widodo R, Mahmood S, Salim N, Awang K, Ahmad N
Polymers (Basel). 2022; 14(15).
PMID: 35893954
PMC: 9330056.
DOI: 10.3390/polym14152991.
Preparation, Characterization and In Vitro Evaluation of Eudragit S100-Coated Bile Salt-Containing Liposomes for Oral Colonic Delivery of Budesonide.
Alghurabi H, Tagami T, Ogawa K, Ozeki T
Polymers (Basel). 2022; 14(13).
PMID: 35808738
PMC: 9268925.
DOI: 10.3390/polym14132693.
Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy.
Jacob E, Borah A, Pillai S, Kumar D
Nanomaterials (Basel). 2020; 10(12).
PMID: 33316984
PMC: 7764399.
DOI: 10.3390/nano10122460.
Development of Antioxidant-Loaded Nanoliposomes Employing Lecithins with Different Purity Grades.
Yarce C, Alhajj M, Sanchez J, Onate-Garzon J, Salamanca C
Molecules. 2020; 25(22).
PMID: 33207762
PMC: 7697641.
DOI: 10.3390/molecules25225344.
Effectiveness of a Controlled 5-FU Delivery Based on FZD10 Antibody-Conjugated Liposomes in Colorectal Cancer In vitro Models.
Scavo M, Cutrignelli A, Depalo N, Fanizza E, Laquintana V, Gasparini G
Pharmaceutics. 2020; 12(7).
PMID: 32664186
PMC: 7408534.
DOI: 10.3390/pharmaceutics12070650.
Relationship between Degree of Polymeric Ionisation and Hydrolytic Degradation of Eudragit E Polymers under Extreme Acid Conditions.
Linares V, Yarce C, Echeverri J, Galeano E, Salamanca C
Polymers (Basel). 2019; 11(6).
PMID: 31181597
PMC: 6630213.
DOI: 10.3390/polym11061010.
Adapting liposomes for oral drug delivery.
He H, Lu Y, Qi J, Zhu Q, Chen Z, Wu W
Acta Pharm Sin B. 2019; 9(1):36-48.
PMID: 30766776
PMC: 6362257.
DOI: 10.1016/j.apsb.2018.06.005.
Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis.
Zhang M, Merlin D
Inflamm Bowel Dis. 2018; 24(7):1401-1415.
PMID: 29788186
PMC: 6085987.
DOI: 10.1093/ibd/izy123.
Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit-Containing Liposomes.
Marti Coma-Cros E, Biosca A, Lantero E, Manca M, Caddeo C, Gutierrez L
Int J Mol Sci. 2018; 19(5).
PMID: 29734652
PMC: 5983818.
DOI: 10.3390/ijms19051361.
Encapsulation of Curcumin-Loaded Liposomes for Colonic Drug Delivery in a pH-Responsive Polymer Cluster Using a pH-Driven and Organic Solvent-Free Process.
De Leo V, Milano F, Mancini E, Comparelli R, Giotta L, Nacci A
Molecules. 2018; 23(4).
PMID: 29570636
PMC: 6017095.
DOI: 10.3390/molecules23040739.
Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.
Ball R, Bajaj P, Whitehead K
Sci Rep. 2018; 8(1):2178.
PMID: 29391566
PMC: 5794865.
DOI: 10.1038/s41598-018-20632-6.
Preparation and evaluation of a novel oral delivery system for low molecular weight heparin.
Lavanya N, Muzib Y, Aukunuru J, Balekari U
Int J Pharm Investig. 2016; 6(3):148-57.
PMID: 27606258
PMC: 4991123.
DOI: 10.4103/2230-973X.187351.